Estron
Изглед
| Klinički podaci | |
|---|---|
| Prodajno ime | Aquacrine, Crinovaryl, Cristallovar, Crystogen |
| Drugs.com | Monografija |
| Način primene | Intravaginalno, oralno |
| Farmakokinetički podaci | |
| Poluvreme eliminacije | 19 h |
| Identifikatori | |
| CAS broj | 53-16-7 |
| ATC kod | G03CA07 (WHO), G03CC04 |
| PubChem | CID 5870 |
| IUPHAR/BPS | 2818 |
| DrugBank | DB00655 |
| ChemSpider | 5660 |
| KEGG | C00468 |
| ChEBI | CHEBI:17263 |
| ChEMBL | CHEMBL1405 |
| Hemijski podaci | |
| Formula | C18H22O2 |
| Molarna masa | 270,366 |
| |
| |
| Fizički podaci | |
| Tačka topljenja | 2.602 °C (4.716 °F) |
| Tačka ključanja | 154 °C (309 °F) |
Estron je organsko jedinjenje, koje sadrži 18 atoma ugljenika i ima molekulsku masu od 270,366 Da.[1][2][3][4]
Osobine
[уреди | уреди извор]| Osobina | Vrednost |
|---|---|
| Broj akceptora vodonika | 2 |
| Broj donora vodonika | 1 |
| Broj rotacionih veza | 0 |
| Particioni koeficijent[5] (ALogP) | 3,9 |
| Rastvorljivost[6] (logS, log(mol/L)) | -4,5 |
| Polarna površina[7] (PSA, Å2) | 37,3 |
Reference
[уреди | уреди извор]- ^ Miyoshi Y, Tanji Y, Taguchi T, Tamaki Y, Noguchi S. Miyoshi, Y.; Tanji, Y.; Taguchi, T.; Tamaki, Y.; Noguchi, S. (2003 Jun). „Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women”. Clin Cancer Res. 9 (6): 2229—33. PMID 12796390. Проверите вредност парамет(а)ра за датум:
|date=(помоћ) - ^ Kajta M, Lason W, Bien E, Marszal M: Neuroprotective effects of estrone on NMDA-induced toxicity in primary cultures of rat cortical neurons are independent of estrogen receptors. Pol J Pharmacol. 2002 Nov-Dec;Kajta, M.; Lasoń, W.; Bień, E.; Marszał, M. (2002). „Neuroprotective effects of estrone on NMDA-induced toxicity in primary cultures of rat cortical neurons are independent of estrogen receptors”. Polish Journal of Pharmacology. 54 (6): 727—9. PMID 12866733.
- ^ Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). „DrugBank 3.0: A comprehensive resource for 'Omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—D1041. PMC 3013709
. PMID 21059682. doi:10.1093/nar/gkq1126.
- ^ Wishart, David S.; Knox, Craig; Guo, An Chi; Cheng, Dean; Shrivastava, Savita; Tzur, Dan; Gautam, Bijaya; Hassanali, Murtaza (2008). „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—D906. PMC 2238889
. PMID 18048412. doi:10.1093/nar/gkm958.
- ^ Ghose, Arup K.; Viswanadhan, Vellarkad N.; Wendoloski, John J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods”. The Journal of Physical Chemistry A. 102 (21): 3762—3772. Bibcode:1998JPCA..102.3762G. doi:10.1021/jp980230o.
- ^ Tetko, Igor V.; Tanchuk, Vsevolod Yu.; Kasheva, Tamara N.; Villa, Alessandro E. P. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID 11749573. doi:10.1021/ci000392t.
- ^ Ertl, Peter; Rohde, Bernhard; Selzer, Paul (2000). „Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID 11020286. doi:10.1021/jm000942e.
Literatura
[уреди | уреди извор]- Hardman JG, Limbird LE, Gilman AG (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill. ISBN 0071354697. doi:10.1036/0071422803.
- Thomas L. Lemke; David A. Williams, ур. (2007). Foye's Principles of Medicinal Chemistry (6. изд.). Baltimore: Lippincott Willams & Wilkins. ISBN 0781768799.
Spoljašnje veze
[уреди | уреди извор]
| Molimo Vas, obratite pažnju na važno upozorenje u vezi sa temama iz oblasti medicine (zdravlja). |